Latest News
A new oral drug designed to improve efficacy of radiotherapy has been shown to be effective and safe as an adjunctive treatment for hard-to-treat cancers.
A Phase I trial of antibody ZW25, which binds to HER2 receptors, has had a good response in patients with HER2-driven cancers.
In a recent Phase II trial involving 35 patients with tumors with AKT mutations capivasertib, an AKT inhibitor, has demonstrated signs of effectiveness.
Journal Articles
Authors discuss the results of this observational real-world study and how sequencing tyrosine kinase inhibitors can extend chemotherapy-free treatment time.
In this review article from Future Oncology find out about the PACIFIC trial design as well as the future of immunotherapy combinations and biomarkers beyond PD-L1.
A new study, published in CNS Oncology estimates the survival benefit of adding tumor treating fields and temozolomide for newly diagnosed glioblastoma patients.
Brain and neurologic
NCRI 2018: Fluorescent marker helps improve accuracy of brain tumor cell removal
Zika vaccine yields promising results for treating glioblastoma
Has the secret of the immortality cancer switch been unlocked?
Breast
NCRI 2018: Women who are ‘larks’ have a lower risk of developing breast cancer, study suggests
ESMO18: New combination therapy for breast cancer may prolong survival
Colorectal
NCRI 2018: Inherited bowel cancer may be preventable by treatment of pre-cancerous stem cells
Data-driven blood test could be a step towards personalized treatment for bowel cancer
Endocrine
NICE recommends new first-line treatment Lenvima against advanced liver cancer
NCRI 2018: HiLo trial suggests low risk thyroid cancer patients can receive lower doses of radiation
Gastrointestinal
A remarkable insight into the cancer journey of Barbara Moss
Conference Chair highlights: World Congress on Gastrointestinal Cancer
Genitourinary
Could urine liquid biopsies help monitor bladder cancer treatment?
NICE approves atezolizumab for advanced bladder cancer patients on the NHS
Gynecologic
SOLO-1: practice-changing results for advanced ovarian cancer patients with BRCA mutation
Vistusertib with paclitaxel shows promise for ovarian and lung cancer in early trial
Head and neck
KEYNOTE-048: pembrolizumab changes the rules for head and neck cancer patients
Diabetics face a higher risk of mouth cancer, with women more at risk
The importance of a multidisciplinary team in the care of head and neck cancer
Hematologic
Personalized prediction scheme for myeloproliferative neoplasms developed
NHS England strikes deal for ground-breaking CAR-T therapy in a new European first
Lung
GioTag: results of real-world study of treatment sequencing in EGFR mutation-positive lung cancer
Pancreatic
ESMO WCGI: Study highlights first-line treatment variations for pancreatic cancer
ESMO WCGI: Adjuvant FOLFIRINOX new standard of care for pancreatic cancer
ASCO18: Preoperative chemoradiotherapy improves survival time for patients with pancreatic cancer
Prostate
Court invalidates patent for prostate cancer drug Zytiga®
Circulating tumor cells: researchers develop mechanism for characterizing function
Rare tumors
Promising Phase I trial for anti-HER2 antibody
Osteoblastoma genetic marker shows promise for identifying aggressive tumors
Skin
NCRI 2018: Male melanoma deaths rising, study reports
FDA approves first and only treatment for advanced cutaneous squamous cell carcinoma
